Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
about
Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for interventionVaccine prevention of maternal cytomegalovirus infectionOngoing burden of disease and mortality from HIV/CMV coinfection in Africa in the antiretroviral therapy eraThe immunological underpinnings of vaccinations to prevent cytomegalovirus disease.Trends in hospitalizations for diagnosed congenital cytomegalovirus in infants and children in AustraliaDevelopment and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvantStrain-specific neutralization of human cytomegalovirus isolates by human sera.The pathogenicity of cytomegalovirus.Cytomegalovirus vaccine developmentMucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant.Dense bodies of human cytomegalovirus induce both humoral and cellular immune responses in the absence of viral gene expressionEvasion of CD8+ T cells is critical for superinfection by cytomegalovirusA spread-deficient cytomegalovirus for assessment of first-target cells in vaccination.Active immunization in the United States: developments over the past decade.Immunoglobulin therapy of fetal cytomegalovirus infection occurring in the first half of pregnancy--a case-control study of the outcome in children.Prevention of maternal cytomegalovirus infection: current status and future prospects.Development of a cytomegalovirus vaccine: lessons from recent clinical trials.Perinatal cytomegalovirus and varicella zoster virus infections: epidemiology, prevention, and treatment.Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cellsIdentification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.Screening for cytomegalovirus during pregnancy.Neutralizing activity of saliva against cytomegalovirus.Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine.CMV antigen-specific CD4+ and CD8+ T cell IFNgamma expression and proliferation responses in healthy CMV-seropositive individuals.Synthetic DNA approach to cytomegalovirus vaccine/immune therapyVaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model.Cytomegalovirus Reinfections Stimulate CD8 T-Memory InflationPriorities for CMV vaccine developmentTargeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy.Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial.Cytomegalovirus vaccines and methods of production (WO20009049138): the emerging recognition of the importance of virus neutralization at the epithelial/endothelial interfaceA live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection.A vaccine based on the rhesus cytomegalovirus UL128 complex induces broadly neutralizing antibodies in rhesus macaques.Update on the current status of cytomegalovirus vaccines.Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.Translational mini-review series on infectious disease: congenital cytomegalovirus infection: 50 years on.Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection.Antibody inhibition of human cytomegalovirus spread in epithelial cell culturesPreclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus.
P2860
Q24570124-DEAE8E3A-18B2-4F6D-BAF7-56B999E038C6Q24645631-C0826712-E811-49F0-B40D-48AD1D4012D4Q26781359-493AD47F-F62C-45D4-8624-967F51262E15Q27692570-E9ECBD49-153A-49C4-8A2A-5C1465972B2FQ33403097-FEF8A6CD-925E-49E1-9B64-0891C276699FQ33585524-4D228499-3DD8-4026-80DD-82E95A308C2EQ33640031-2F243F6D-6E11-4C68-BD6F-48E128CD79B8Q33697113-D067A80D-ADD5-4EC2-ADBC-B3C418E01E27Q33702990-26298344-730B-4F49-8B95-497360F76298Q33782029-4D7EC699-1990-44B4-80A3-254A39283B28Q33807009-6A9EB5AD-2D41-44D0-9BF4-82304F02CF3AQ33903818-E268D81B-36CA-4721-9A50-27D3D4C91CF4Q33964131-F7C24F25-1AEF-4209-83D8-2DAEBDBC977AQ33975799-3BA0EE88-FEC8-4220-BCF7-55549470C6EFQ34238172-FA84711B-6E80-4993-AAA4-F9B1B1A321CBQ34272089-13BE515B-EC9E-4DCA-80DE-83FACA74A12AQ34451960-015DB358-AD4E-46E6-B61D-A19844813A22Q34667953-636971B2-9A9C-4091-8489-D28B6B908192Q34885758-DC28B510-57D6-41F8-A1F8-DCD13DE5641CQ34992770-A8EEBEA4-D038-4BBC-B86A-0EFD8A4FA8DEQ35155128-C5A5A9F0-F219-4F9D-A94D-36CA3A4105EDQ35191120-DD7C9AE6-BF10-413A-8133-486709446AEBQ35230656-9A3A051E-A799-40D9-8CCD-DCB572F8D6ADQ35609192-85707E06-D49B-45A6-AC29-BB2B5C6C82FBQ36012455-5A661A9C-4582-4A42-87AC-836100EC5CE2Q36069582-C497255A-5137-47E6-B3C9-D5DFA56C96F6Q36080805-9A5BAE3A-913B-4FE7-9F3F-36C419B6C2ABQ36199934-02CBBD65-90E2-4D15-BEF0-43539EB2AB06Q36216553-A9B9AA30-E494-42F2-B7D7-C19299DE0018Q36315171-C0CBFDE1-ACAD-4B21-96AD-8347AD90AE95Q36430938-D4DD3403-DC80-4DF9-A272-EC48D8463033Q36517096-FC2F6E7C-16B6-4409-B0F5-86C587A1CE2CQ36517130-1F40C0F0-B040-4C1F-A341-FADD6104B833Q36559845-1C878BAB-51B0-405B-ABE2-8C16BDC17CA8Q36678423-A58AD74A-5442-4795-A182-6D31E92C3B6BQ36694861-7F4D2715-9075-4ED3-8C72-D80B21442D82Q36884194-83C2C17F-E5A6-4730-B5C7-B257E52B6CAFQ36973592-0ED7D897-0215-4AD9-B222-E6E3D4E9D81AQ37174327-DA6A96F9-3F49-400F-ABD8-D25527E7C5FCQ37197051-D4B8C6B2-D41A-46D6-907F-3074AD9509DB
P2860
Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Immunity induced by primary hu ...... ong women of childbearing age.
@en
Immunity induced by primary hu ...... ong women of childbearing age.
@nl
type
label
Immunity induced by primary hu ...... ong women of childbearing age.
@en
Immunity induced by primary hu ...... ong women of childbearing age.
@nl
prefLabel
Immunity induced by primary hu ...... ong women of childbearing age.
@en
Immunity induced by primary hu ...... ong women of childbearing age.
@nl
P2093
P356
P1476
Immunity induced by primary hu ...... ong women of childbearing age.
@en
P2093
P356
10.1093/INFDIS/171.1.26
P407
P577
1995-01-01T00:00:00Z